Wechselwirkungen · Clopidogrel ratiopharm
Clopidogrel ratiopharm 75 mg film-coated tablets · Abschnitt 4.5 · PDF-Seite 8
HOS-222540 · Präparat HOS-217040
A significantly reduced platelet inhibition has been shown in HIV patients treated with ritonavir-or cobicistat-boosted ART. Although the clinical relevance of these findings is uncertain, there have been spontaneous reports of HIV-infected patients treated with ritonavir boosted ART, who have experienced re-occlusive events after de-obstruction or have suffered thrombotic events under a clopidogrel loading treatment schedule. Average platelet inhibition can be decreased with concomitant use of clopidogrel and ritonavir. Therefore, concomitant use of clopidogrel with ART boosted therapies should be discouraged.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): clopidogrel (HOS-087927) ritonavir (HOS-084521)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-03-26T01:00:00Z · SHA-256 bb1e41aa3fcc130d790cea18e2c1ae62fcbdb4cf2e59a3e8c2e4a3977273809f · Passage 81aaf24163fdcb5a08d994bf88c1bc23137bd4bcb0f298c8d3ca6c7012df5a88 · Zeichen 6015–6633 im Abschnitt